Your body uses the KCNH1 gene to make a potassium channel, a tiny gate that helps control electrical signals in the brain and supports normal growth and development. When this channel does not work as expected, some people develop a rare genetic condition with seizures, developmental delay, learning difficulties, and changes in the nails, bones, or facial features. Many pathogenic variants in the KCNH1 gene make the channel too active rather than simply switching it off.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or regulate processes in the body. Some genes carry the directions for building proteins, the parts of cells that do the work. Others mainly help set when certain processes happen, where they take place, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a closer look at this topic, you can read more in the LearnHub.
Overview
KCNH1Gene function
What if the gene works
The KCNH1 gene helps make a potassium channel, a tiny gate that controls electrical signals in cells. It is especially active in the brain and helps nerve cells send signals in a steady, controlled way.
Risk
What if the gene does not work
Variants in the KCNH1 gene can affect brain development and nerve signaling, often causing developmental delay, seizures, and differences in the nails, fingers, face, or gums. Milder and severe variants can shape when features begin and how strongly they appear.
Treatment
What does that mean for your treatment
No treatment or drug selection approach tied specifically to the KCNH1 gene is currently established in clinical guidelines. The KCNH1 gene is being studied mainly as a cancer biomarker and possible drug target, but this has not yet changed routine treatment decisions.
Conditions associated with KCNH1
Gene function
What if the gene works
Your cells use the KCNH1 gene to manage tiny electrical signals. It helps build a potassium channel, a small doorway in the cell surface that opens when the cell’s charge changes. This supports steady communication between cells, especially in the brain.
The KCNH1 gene helps form a channel that lets potassium move out of the cell at the right time. This controlled flow supports the cell’s normal electrical activity.
In nerve cells, this channel helps shape each electrical message and the reset that follows. That timing supports smooth communication between brain cells.
By helping maintain the right charge across the cell surface, the KCNH1 gene supports routine cell activity. This is part of how the KCNH1 gene works in nerve cells and other tissues.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease linked variants in the KCNH1 gene change the shape or timing of its potassium channel so it opens too easily or closes too slowly, which alters electrical signaling between cells. This is how KCNH1 gene variants affect potassium channel activity, and different DNA changes can have milder or stronger effects on channel timing or on how much channel reaches the cell surface. Stronger overactive variants often track with earlier symptoms or more marked features.
How variants are linked to conditions
Pathogenic variants in the KCNH1 gene cause Temple-Baraitser syndrome and Zimmermann-Laband syndrome type 1. These conditions often involve developmental delay or intellectual disability, seizures, and changes in the nails, fingers, toes, or facial features. Some variants are also linked to developmental and epileptic encephalopathy. This is why KCNH1 gene variants linked to epilepsy and developmental delay are usually discussed as part of these rare genetic conditions.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology. In the general population, most do not directly affect health and instead reflect normal human diversity. For many genes, a variant associated with a condition points to a possible link, not a definite diagnosis, particularly when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KCNH1-related conditions, risk is mainly set by whether someone has a disease-causing change in the KCNH1 gene, and many of these changes happen for the first time in the child rather than being passed down. There is not enough evidence to say that lifestyle or environmental factors meaningfully change this risk.
Inheritance of KCNH1 variants
KCNH1-related conditions are usually inherited in an autosomal dominant pattern, which means one altered copy of the KCNH1 gene can be enough to cause the condition. If a parent carries a disease-causing variant, each child has a 50% chance of inheriting it. In understanding how KCNH1 variants are inherited, it also helps to know that many reported cases happen because of a new, de novo variant, meaning the change started in the child and was not inherited from either parent.
What does my KCNH1 result mean for my family?
For KCNH1, family implications are usually based on a dominant pattern, which means a parent, sibling, or child may also carry the same gene change. Close relatives may want to talk with their care team about whether family testing would help clarify their own chances of being affected. Some KCNH1 changes happen new in one person and are not inherited from either parent, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
To look for changes linked to KCNH1-related conditions, doctors use KCNH1 genetic testing to search for variants in a blood or saliva sample. A lab reads the DNA code of the KCNH1 gene and compares it with the usual sequence. Results may show a pathogenic variant, a benign variant, or a finding that is still unclear.
When should I consider getting a genetic test?
Consider KCNH1 genetic testing when a child has unexplained developmental delay, seizures, and a pattern of physical features such as unusual nails or enlarged gums that suggest a rare genetic condition. Testing may also help clarify the cause when a doctor suspects Temple-Baraitser syndrome or Zimmermann-Laband syndrome.
A genetic result is only one part of your health story
Genetic results can offer useful insight, but how much they reveal depends on the condition and the specific type of variant. Many other factors, including lifestyle, environment, age, and medical history, also shape how the body functions over time. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is most helpful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same drug may work well for one person, seem less effective for another, or cause more side effects in someone else. In part, this happens because inherited differences can change how the body breaks down, moves, or responds to a medication, and these differences are a common part of normal human biology.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way a person responds to medication. It studies the relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes influence how strongly a drug works or how the body handles it. This information can help guide more informed, individualized treatment decisions. To explore this subject further, more information is available in the LearnHub.
Drugs influenced by the KCNH1 gene
When should I seek medical advice?
There isn't yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, new symptoms, or how a treatment may affect you are best discussed with your doctor.
History
KCNH1 entered medical genetics through earlier work on a related gene in fruit flies called ether à go-go, a name that stood out because affected flies developed unusual leg shaking after ether exposure. Initially understood only through visible traits, later recognized as tied to a specific gene family, this work helped researchers identify the human KCNH1 gene in the 1990s. From these first observations, research expanded steadily. In the 2010s, KCNH1 gained clearer clinical importance when variants in this gene were linked to rare developmental conditions, including Temple-Baraitser syndrome and forms of Zimmermann-Laband syndrome. These discoveries connected an eye catching laboratory finding to real experiences in affected families and made KCNH1 part of the growing story of rare disease genetics.